NEXT.BIO 2025 - Next era of AI-driven drugs & therapeutics
- Date
- 2025-10-06
- Location
- San Francisco, CA, USA
- Host
- Next Sequence Global Events
About this event
AI is changing how drugs are discovered, designed, and developed, but the real question is what comes next when faster models meet real biological complexity. NEXT.BIO 2025 is built for people who want to look past the hype and get into the practical frontier: how AI-driven therapeutics are being shaped by better tools, more autonomous workflows, stronger scientific judgment, and a more connected ecosystem. If you work anywhere near biotech, machine learning, translational science, venture, or company building, this is a chance to be in the room with others focused on the same shift. Expect serious conversations, useful context, and the kind of in-person networking that helps ideas sharpen quickly. About the Event NEXT.BIO 2025 - Next era of AI-driven drugs & therapeutics is an in-person gathering in San Francisco centered on the emerging landscape of AI-enabled drug discovery and therapeutic development. The focus is not just on AI as a general trend, but on what the next era actually looks like when autonomy, scientific workflows, and real-world biotech execution start to converge. This event is designed as both a content and community experience. That means attendees can expect a mix of thoughtful discussion, current perspectives from the field, and plenty of time to connect with peers working across adjacent parts of the ecosystem. Whether you are deeply technical or more focused on product, strategy, investing, or partnerships, the format supports both learning and relationship-building. Because the event is grounded in themes like AI, autonomy, community, networking, and meetup, the tone is likely to be collaborative and forward-looking rather than overly formal. It is a space for people who want to compare notes on where the field is going, what is actually working, and where the biggest open questions still are. What to Expect You should expect conversations that sit at the intersection of biology, computation, and execution. Rather than treating AI in therapeutics as a vague category, the event theme points toward concrete questions: how autonomous systems may reshape research processes, how teams are thinking about model-driven decision-making, and how new approaches can move from promise to practical impact. Across the afternoon, the experience will likely combine structured programming with informal interaction. That makes it useful whether you come primarily to learn, to meet collaborators, or to get a better read on the direction of the market and science. What the afternoon may include: Focused talks or discussions on the next phase of AI-driven drugs and therapeutics Perspectives from builders and operators thinking about autonomy in research and development workflows Peer conversations with people from biotech, AI, research, startups, and the broader life sciences community Networking time designed for meaningful introductions rather than rushed exchanges Cross-functional insight spanning science, tooling, company creation, and ecosystem trends Because this is an in-person meetup-style event, some of the most useful moments may happen between sessions: quick introductions that turn into future meetings, candid exchanges about what is difficult right now, and a better understanding of who is building what in the space. Why Attend The AI-biotech conversation is moving fast, and it is increasingly difficult to separate broad claims from grounded progress. One of the strongest reasons to attend is simple: being in a room with smart, relevant people helps you update your thinking faster. You get context that is hard to pick up from headlines alone, and you can test your own assumptions against others who are working close to the problem. This event is especially valuable if you want to understand how the field is evolving beyond first-generation excitement. The phrase "next era" matters here. It suggests a focus on what comes after the initial wave of enthusiasm: operational maturity, better integration into research pipelines, stronger interdisciplinary collaboration, and more realistic views of where AI can create leverage in therapeutics. You may come away with: A clearer view of the opportunities and bottlenecks in AI-driven therapeutics Better language for discussing autonomy in a biotech context New connections across research, startups, investing, and applied AI Fresh perspective on how different parts of the ecosystem are approaching similar problems Potential collaborators, customers, partners, or simply people worth knowing as the space develops For many attendees, the value will be both intellectual and practical. You are not just showing up to hear about a trend. You are showing up to meet the people interpreting it, building with it, and helping define where it goes next. Practical Details NEXT.BIO 2025 takes place in person in San Francisco, USA on Monday, October 6 at 1:00 PM PDT. The in-person format matters: if your goal is substantive discussion and strong networking, being physically present creates a very different quality of interaction than online events can offer. San Francisco is a natural setting for this conversation, given its concentration of biotech, AI, startups, and investors. If you are local, this is an efficient way to plug into a focused community discussion. If you are visiting from out of town, it offers a useful anchor for meetings and broader ecosystem connection. A few practical things to keep in mind: Plan to arrive a little early so you can settle in and start meeting people before the main programming begins Bring context on what you are working on, what questions you are exploring, and what kinds of people you hope to meet Be ready for a cross-disciplinary audience; some of the best conversations will happen between people who approach the same problem from different angles If networking is a priority, leave space after the event in case conversations run long or turn into follow-up plans If your work touches AI, drug discovery, therapeutics, or the infrastructure around them, this is exactly the kind of room that can sharpen your perspective and expand your network in a single afternoon.
Who should attend
If you want a clearer view of where AI-driven therapeutics is actually heading, and you value being in the room with people actively shaping that future, this event is for you. - **You work in biotech or pharma** and want to understand how AI and more autonomous workflows may change discovery, development, or research operations. - **You are a founder, operator, or startup team member** building tools, platforms, or therapeutics and want sharper market context plus high-signal conversations with peers. - **You are an ML, data, or software professional** interested in applied biology and want to connect with people translating technical capability into therapeutic impact. - **You are a scientist or researcher** curious about how computational approaches are being integrated into real drug and therapeutics work, beyond surface-level claims. - **You are an investor, advisor, or ecosystem builder** looking for a more grounded read on the AI-bio landscape and the people driving it forward. - **You are community-minded and cross-functional** and know that some of the best opportunities come from meeting people outside your immediate discipline. You do not need to fit a single job title. If you care about the next era of AI in drugs and therapeutics, want informed conversation instead of noise, and are open to meeting smart people across the space, you will likely feel at home here.